Relative risk of being prescribed various drugs for women compared with men*, for men and women aged ⩾75 years compared with <75 years†, and for Carstairs deprivation category 5 compared with Carstairs deprivation category 1‡
| Women v men | Men≥75 years v <75 years | Women≥75 years v <75 years | Carstairs deprivation category 5 v 1 | |||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | p Value | OR (95% CI) | p Value | OR (95% CI) | p Value | OR (95% CI) | p Value | |
| *Adjusted for practice, age, deprivation category and co-morbidity; †adjusted for practice, age, deprivation category and co-morbidity; ‡adjusted for age, sex, type of practice and co-morbidity; §aspirin or clopidogrel; ¶antiplatelet drug + statin + angiotensin converting enzyme inhibitor (ACEI). | ||||||||
| ARB, angiotensin receptor blocker; CCB, calcium channel blocker; OR, odds ratio. | ||||||||
| β blockers | 0.86 (0.78 to 0.93) | <0.001 | 0.67 (0.59 to 0.78) | <0.001 | 0.71 (0.62 to 0.81) | <0.001 | 0.94 (0.78 to 1.12) | 0.485 |
| CCB | 0.85 (0.78 to 0.93) | <0.001 | 1.03 (0.90 to 1.19) | 0.625 | 1.04 (0.91 to 1.19) | 0.536 | 1.25 (1.04 to 1.48) | 0.015 |
| Nitrates | 0.96 (0.88 to 1.04) | 0.312 | 1.42 (1.23 to 1.62) | <0.001 | 1.24 (1.08 to 1.41) | 0.002 | 1.25 (1.05 to 1.50) | <0.012 |
| ACEI/ARB | 0.69 (0.63 to 0.76) | <0.001 | 0.76 (0.65 to 0.89) | <0.001 | 0.78 (0.66 to 0.91) | 0.001 | 1.51 (1.23 to 1.85) | <0.001 |
| Statins | 0.83 (0.76 to 0.91) | <0.001 | 0.30 (0.26 to 0.34) | <0.001 | 0.33 (0.29 to 0.38) | <0.001 | 0.92 (0.77 to 1.10) | 0.368 |
| Antiplatelet§ | 0.82 (0.74 to 0.90) | <0.001 | 1.15 (0.98 to 1.35) | 0.079 | 0.96 (0.84 to 1.11) | 0.618 | 1.08 (0.89 to 1.32) | 0.439 |
| Warfarin | 0.79 (0.64 to 0.94) | <0.035 | 0.84 (0.62 to 1.14) | 0.266 | 0.85 (0.61 to 1.20) | 0.363 | 1.81 (1.15 to 2.85) | 0.01 |
| Optimal treatments¶ | 0.68 (0.60 to 0.76) | <0.001 | 0.51 (0.42 to 0.62) | <0.001 | 0.53 (0.43 to 0.65) | <0.001 | 1.64 (1.29 to 2.09) | <0.001 |